GO:0036088 D-serine catabolic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036088 (D-serine catabolic process) describes the biochemical breakdown of D-serine, the D-enantiomer of serine and a key co-agonist of NMDA receptors.
• D-serine catabolism controls synaptic D-serine levels and thus NMDA receptor activity, which is essential for synaptic plasticity and cognitive processes.
• Key enzymes include D-amino acid oxidase (DAO), serine hydroxymethyltransferase (SHMT), and D-serine dehydratase (DSD), which degrade D-serine to pyruvate, ammonia, and other metabolites.
• Dysregulation of D-serine catabolism is linked to Alzheimer's disease, schizophrenia, and peripheral metabolic disorders.
• CRISPR knockout, point mutation, and overexpression models are powerful tools to dissect the role of D-serine catabolic enzymes in health and disease.
• EDITGENE provides custom cell models and CRISPR library screening to study D-serine catabolic process genes with high specificity and reproducibility.
Description
D-serine catabolic process (GO:0036088) is the set of biochemical reactions that degrade D-serine, a D-amino acid that acts as a co-agonist at the NMDA receptor glycine site. Unlike L-serine, which is primarily used for protein synthesis and one-carbon metabolism, D-serine is synthesized by serine racemase and must be tightly regulated to maintain proper synaptic function. The catabolic breakdown of D-serine is therefore critical for controlling its extracellular concentration and preventing excitotoxicity or cognitive deficits. Researchers study this process to understand how D-serine levels are maintained in the brain and periphery, and how its dysregulation contributes to neurological and psychiatric disorders. The QuickGO definition states that GO:0036088 encompasses the chemical reactions and pathways resulting in the breakdown of D-serine, including its conversion to pyruvate, ammonia, and other metabolites.
D-serine catabolic process At A Glance
| GO ID | GO:0036088 |
|---|---|
| GO term | D-serine catabolic process |
| Ontology | biological_process |
| Synonym | D-serine breakdown, D-serine catabolism, D-serine degradation |
| Major function | Breakdown of D-serine to regulate its cellular and extracellular levels |
| Key enzymes | DAO, DSD, SHMT |
| Subcellular location | Peroxisomes (DAO), cytosol (DSD, SHMT) |
| Pathways involved | D-amino acid metabolism, one-carbon metabolism |
| Related diseases | Alzheimer's disease, schizophrenia, peripheral metabolic disorders |
What Is GO:0036088?
The D-serine catabolic process (GO:0036088) refers to the chemical reactions and pathways that result in the breakdown of D-serine, the D-enantiomer of the amino acid serine. This process includes enzymatic reactions that convert D-serine into simpler molecules such as pyruvate, ammonia, and hydrogen peroxide, primarily through the action of enzymes like D-amino acid oxidase (DAO) and D-serine dehydratase (DSD). It is a biological process that regulates the availability of D-serine for NMDA receptor co-activation and other signaling roles.
Why Is D-serine catabolic process Important in Cell Biology?
D-serine catabolic process is crucial because D-serine is a potent co-agonist of the NMDA receptor, and its degradation directly controls the receptor's activity, influencing synaptic plasticity, learning, and memory. Dysregulation of D-serine catabolism leads to altered NMDA receptor function, which is implicated in schizophrenia, Alzheimer's disease, and other cognitive disorders. In peripheral tissues, D-serine catabolism affects metabolic homeostasis and oxidative stress responses. Thus, understanding this process provides insights into neuropsychiatric and metabolic diseases and offers potential therapeutic targets.
• Regulates NMDA receptor activity and synaptic plasticity.
• Controls D-serine levels in the brain and periphery.
• Implicated in Alzheimer's disease cognitive deficits.
• Linked to schizophrenia pathophysiology.
• Affects sleep deprivation-induced intestinal ROS accumulation.
• Involved in one-carbon metabolism via SHMT.
• Potential target for cognitive enhancers and neuroprotective drugs.
• Provides biomarkers for metabolic and neurological disorders.
• Enables CRISPR-based studies of D-serine catabolic enzymes.
• Relevant to cancer metabolism through serine/glycine pathways.
What Happens During D-serine Catabolic process?
Oxidative Deamination by D-Amino Acid Oxidase (DAO)
In simple terms: DAO breaks down D-serine by removing an ammonia group and producing hydrogen peroxide.
D-amino acid oxidase (DAO) catalyzes the oxidative deamination of D-serine to α-keto acid, which spontaneously hydrolyzes to pyruvate and ammonia, generating hydrogen peroxide. This reaction primarily occurs in peroxisomes and is a major route for D-serine degradation in the brain and peripheral tissues. DAO activity is tightly regulated and influences D-serine availability for NMDA receptor co-activation.
Dehydration by D-Serine Dehydratase (DSD)
In simple terms: DSD removes water from D-serine to form pyruvate and ammonia.
D-serine dehydratase (DSD) catalyzes the pyridoxal phosphate-dependent dehydration of D-serine to pyruvate and ammonia. This enzyme provides an alternative catabolic route, particularly in bacteria and some eukaryotic tissues. In mammals, DSD activity is less characterized but contributes to D-serine clearance.
Tetrahydrofolate-Dependent Cleavage by SHMT
In simple terms: SHMT can cleave D-serine using tetrahydrofolate to produce glycine and one-carbon units.
Serine hydroxymethyltransferase (SHMT) exhibits novel tetrahydrofolate-dependent D-serine dehydratase activity, converting D-serine to pyruvate and ammonia while generating 5,10-methylene tetrahydrofolate. This links D-serine catabolism to one-carbon metabolism and folate cycle, affecting nucleotide synthesis and methylation reactions.
Integration with L-Serine and Glycolysis Pathways
In simple terms: D-serine breakdown products feed into energy production and other metabolic pathways.
The pyruvate generated from D-serine catabolism enters the tricarboxylic acid cycle for energy production, while ammonia is detoxified via the urea cycle. In astrocytes, D-serine catabolism is interconnected with L-serine synthesis and glycolysis, influencing neuronal support and cognitive function. This metabolic integration highlights the importance of D-serine catabolism in overall cellular metabolism.
Key Genes Involved in GO:0036088 D-serine catabolic process
The following genes encode enzymes and transporters directly involved in D-serine catabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DAO | Oxidative deamination of D-serine to pyruvate and ammonia | Key enzyme in D-serine clearance; linked to schizophrenia and ALS |
| DSD | Dehydration of D-serine to pyruvate and ammonia | Bacterial and eukaryotic D-serine catabolism; potential antibiotic target |
| SHMT1 | Tetrahydrofolate-dependent cleavage of D-serine | Connects D-serine catabolism to one-carbon metabolism |
| SHMT2 | Mitochondrial SHMT; D-serine dehydratase activity | Involved in cancer metabolism and D-serine catabolism |
| SRR | Serine racemase; synthesizes D-serine (opposite of catabolism) | Regulates D-serine levels; target for cognitive disorders |
| GOT1 | Transaminates D-serine metabolites | Links D-serine catabolism to TCA cycle |
| GOT2 | Mitochondrial transaminase | Metabolic integration of D-serine breakdown |
| GLUD1 | Glutamate dehydrogenase; handles ammonia from D-serine | Ammonia detoxification after D-serine catabolism |
| SLC7A11 | Cystine/glutamate antiporter; affects D-serine uptake | Indirectly influences D-serine catabolism |
| GLS | Glutaminase; produces glutamate for D-serine synthesis | Indirect role in D-serine metabolism |
| PHGDH | Phosphoglycerate dehydrogenase; L-serine synthesis | Affects D-serine precursor availability |
| PSAT1 | Phosphoserine aminotransferase | L-serine synthesis pathway |
| PSPH | Phosphoserine phosphatase | L-serine synthesis; impacts D-serine levels |
| MTHFD1 | One-carbon metabolism enzyme | Linked to SHMT-mediated D-serine catabolism |
| MTHFD2 | Mitochondrial one-carbon enzyme | Integrates D-serine catabolism with folate cycle |
| GLDC | Glycine decarboxylase; processes glycine from D-serine | Connects D-serine catabolism to glycine cleavage |
| AMT | Aminomethyltransferase; glycine cleavage system | Downstream of D-serine catabolism |
How Is D-serine catabolic process Regulated?
D-serine catabolic process is regulated at multiple levels. DAO activity is modulated by its substrate availability and by interacting proteins such as p47phox. In the brain, D-serine catabolism is influenced by neuronal activity and astrocyte-neuron lactate shuttling, which affects glycolytic flux and D-serine levels. Sleep deprivation alters intestinal D-serine catabolism and ROS accumulation, indicating systemic regulation. Additionally, SHMT-mediated D-serine catabolism is regulated by tetrahydrofolate availability and one-carbon status. These regulatory mechanisms ensure D-serine homeostasis and proper NMDA receptor function.
D-serine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DAO | Schizophrenia, ALS | DAO knockout mice, neuronal cell lines |
| SHMT1/2 | Cancer, one-carbon metabolism disorders | SHMT1/2 knockout cell lines, xenografts |
| SRR | Schizophrenia, Alzheimer's disease | SRR knockout mice, iPSC-derived neurons |
| PHGDH | Alzheimer's disease, serine deficiency | PHGDH knockout astrocytes, organoids |
| SLC7A11 | Sleep deprivation-induced ROS, cancer | SLC7A11 knockout intestinal cells |
Alzheimer's Disease
Impaired glycolysis-derived L-serine production in astrocytes contributes to cognitive deficits in Alzheimer's disease, and D-serine catabolism is altered in this context. Reduced D-serine levels due to enhanced catabolism may impair NMDA receptor function and synaptic plasticity, exacerbating cognitive decline.
Schizophrenia
D-serine catabolism dysregulation leads to decreased D-serine availability, contributing to NMDA receptor hypofunction observed in schizophrenia. DAO inhibitors and D-serine supplementation are investigated as therapeutic strategies.
Peripheral Metabolic Disorders
D-serine catabolism in peripheral tissues affects oxidative stress and metabolic homeostasis. Sleep deprivation-induced intestinal ROS accumulation is linked to altered D-serine catabolism. D-serine catabolism also influences glucose metabolism and insulin sensitivity.
From D-serine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does DAO knockout alter D-serine levels and NMDA receptor function? | DAO knockout mouse or human cell line |
| What is the effect of a point mutation in SHMT2 on D-serine catabolism? | SHMT2 point-mutation knock-in cell line |
| Can overexpression of DSD reduce D-serine toxicity? | DSD overexpression cell model |
| How does tagged DAO localize in peroxisomes? | DAO-GFP knock-in cell line |
| What genes regulate D-serine catabolism under sleep deprivation? | CRISPR library screening in intestinal organoids |
| Does SRR knockout affect D-serine catabolism and cognition? | SRR knockout mouse and behavioral tests |
How to Study the D-serine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | D-serine and metabolite levels | Quantify catabolic flux in cells/tissues |
| Enzyme activity assay | Catalytic activity of DAO, DSD, SHMT | Characterize enzyme kinetics and inhibitors |
| CRISPR knockout screening | Gene essentiality and regulators | Identify novel D-serine catabolism genes |
| Western blot | Protein expression levels | Validate knockout or overexpression |
| Immunofluorescence | Subcellular localization | Determine peroxisomal vs cytosolic localization |
| RNA-seq | Transcriptional changes | Assess gene expression after perturbations |
| Seahorse assay | Glycolysis and oxidative phosphorylation | Measure metabolic shifts due to D-serine catabolism |
| Behavioral tests | Cognitive function in animal models | Link D-serine catabolism to memory |
Metabolomics and D-Serine Quantification
Targeted metabolomics using LC-MS/MS allows precise quantification of D-serine and its catabolic products (pyruvate, ammonia) in cells and tissues. This method is essential to measure flux through D-serine catabolic process and validate enzyme functions.
Enzyme Activity Assays
In vitro enzyme assays with recombinant DAO, DSD, or SHMT measure catalytic activity using D-serine as substrate and detect product formation spectrophotometrically or fluorometrically. These assays help characterize kinetic parameters and inhibitor effects.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that regulate D-serine catabolism and its impact on cell fitness or ROS levels. This approach is powerful for discovering novel regulators and therapeutic targets.
Imaging and Subcellular Localization
Fluorescent tagging of DAO or DSD (e.g., GFP knock-in) enables live-cell imaging to track subcellular localization and dynamics of D-serine catabolic enzymes. This reveals peroxisomal targeting and interactions with other organelles.
How CRISPR Can Be Used to Study GO:0036088 D-serine catabolic process
Knockout
CRISPR knockout of DAO, DSD, or SHMT genes in cell lines or mice abolishes D-serine catabolic activity, leading to elevated D-serine levels and altered NMDA receptor signaling. These models are used to study the physiological consequences of D-serine accumulation.
Point Mutation
Introducing point mutations in catalytic residues of DAO or SHMT via CRISPR base editing or HDR allows precise dissection of enzymatic function and substrate specificity. Such models help distinguish between catalytic and non-catalytic roles.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA) of DAO or DSD enables real-time tracking of enzyme localization and interaction partners. This approach is valuable for understanding spatiotemporal regulation of D-serine catabolism.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of DSD or DAO increases D-serine catabolic flux, reducing D-serine levels and potentially modulating NMDA receptor activity. These models are used to test therapeutic hypotheses.
How EDITGENE Supports D-serine catabolic process Research
Researchers studying D-serine catabolic process-related genes often need to determine whether a candidate gene is causally involved in D-serine breakdown, how mutations affect enzyme activity, and whether modulating its expression alters cellular phenotypes. EDITGENE provides end-to-end CRISPR solutions to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for D-serine catabolic process research.
Frequently Asked Questions About D-serine catabolic process
What is D-serine catabolic process?
D-serine catabolic process (GO:0036088) is the set of biochemical reactions that break down D-serine into pyruvate, ammonia, and other metabolites, primarily through enzymes like DAO, DSD, and SHMT.
What genes are involved in D-serine catabolic process?
Key genes include DAO, DSD, SHMT1, SHMT2, and SRR, which encode enzymes that directly or indirectly regulate D-serine breakdown.
Why is D-serine catabolism important for brain function?
It controls D-serine levels, which is a co-agonist of NMDA receptors, thereby influencing synaptic plasticity, learning, and memory.
How is D-serine catabolic process linked to Alzheimer's disease?
Impaired D-serine catabolism can lead to altered NMDA receptor activity and cognitive deficits observed in Alzheimer's disease.
What enzymes degrade D-serine?
D-amino acid oxidase (DAO), D-serine dehydratase (DSD), and serine hydroxymethyltransferase (SHMT) are the main enzymes that degrade D-serine.
Can CRISPR be used to study D-serine catabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of D-serine catabolic genes and their functions.
What is the role of DAO in D-serine catabolism?
DAO catalyzes the oxidative deamination of D-serine to pyruvate and ammonia, a major route for D-serine clearance in the brain and periphery.
How does sleep deprivation affect D-serine catabolism?
Sleep deprivation alters intestinal D-serine catabolism and ROS accumulation, indicating a link between D-serine breakdown and oxidative stress.
What methods are used to study D-serine catabolic process?
LC-MS/MS metabolomics, enzyme activity assays, CRISPR screening, and imaging are commonly used to study D-serine catabolism.
What cell models are available for D-serine catabolism research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression cell models for DAO, DSD, SHMT, and other related genes.
Conclusion
D-serine catabolic process (GO:0036088) is a fundamental biological process that regulates D-serine levels and NMDA receptor function, with profound implications for brain health and disease. Understanding its mechanisms through CRISPR-based models and advanced metabolomics can reveal new therapeutic targets for Alzheimer's disease, schizophrenia, and metabolic disorders. EDITGENE offers comprehensive services to accelerate research in this field.
References
- 1. Zheng F et al.. 2025. Role of d-serine in intestinal ROS accumulation after sleep deprivation.. Sci Adv 11(29):eadr8592 PMID: 40680136
- 2. Le Douce J et al.. 2020. Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease.. Cell Metab 31(3):503-517.e8 PMID: 32130882
- 3. Wolosker H. 2018. The Neurobiology of d-Serine Signaling.. Adv Pharmacol 82:325-348 PMID: 29413526
- 4. Fernández-Moncada I et al.. 2024. A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice.. Nat Commun 15(1):6842 PMID: 39122700
- 5. Mountadem S et al.. 2025. D-Serine's Journey Between Stars and Synapses.. Neurochem Res 50(5):327 PMID: 41085755
- 6. Coyle JT et al.. 2020. D-Serine, the Shape-Shifting NMDA Receptor Co-agonist.. Neurochem Res 45(6):1344-1353 PMID: 32189130
- 7. Miyamoto T et al.. 2024. Novel tetrahydrofolate-dependent d-serine dehydratase activity of serine hydroxymethyltransferases.. FEBS J 291(2):308-322 PMID: 37700610
- 8. Montesinos Guevara C et al.. 2016. The role of D-serine in peripheral tissues.. Eur J Pharmacol 780:216-23 PMID: 27038518
